Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
07/2006
07/06/2006US20060147531 Tamsulosin core with a coating of polyvinylpyrrolidone and polyfinylacetate
07/06/2006US20060147530 Sustained release compositions containing alfuzosin
07/06/2006US20060147529 Granulate comprising an oily substance, corresponding production method and tablet
07/06/2006US20060147528 Extended release, multiple unit dosage forms of phenytoin sodium and processes for their preparation
07/06/2006US20060147527 Controlled release preparations comprising tramadol and topiramate
07/06/2006US20060147526 Pharmaceutical formulations comprising ß-2 adrenoreceptor agonists and xanthines
07/06/2006US20060147525 Lipophilic drug compositions
07/06/2006US20060147524 Melt-formulated, multi-particulate oral dosage form
07/06/2006US20060147523 Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof
07/06/2006US20060147522 Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
07/06/2006US20060147521 Sustained release ranolazine formulations
07/06/2006US20060147520 Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation
07/06/2006US20060147519 Process for the preparation of robust formulations of valacyclovir hydrochloride tablets
07/06/2006US20060147518 Water soluble; vinorelbine ditartrate in polyoxyethylene glycol; for oral administration
07/06/2006US20060147517 Taste masking system for non-plasticizing drugs
07/06/2006US20060147516 Taste masking system for alprazolam
07/06/2006US20060147515 Bioactive dispersible formulation
07/06/2006US20060147514 Method for introducing antisense oligonucleotides into eucaryotic cells
07/06/2006US20060147513 Methods of forming targeted liposomes loaded with a therapeutic agent
07/06/2006US20060147512 selectively exploit chemical variations between normal cells and cancer cells to inhibit or prevent the proliferation of cancerous cells; biologically acceptable copper compound
07/06/2006US20060147511 Liposomal glucocorticoids
07/06/2006US20060147510 Method for treating non-neuropathic pain
07/06/2006US20060147509 Composition for vaccination
07/06/2006US20060147507 Hot flash treatment system
07/06/2006US20060147506 Foam with germproof and mildew-proof effects
07/06/2006US20060147505 Water-dispersible wet wipe having mixed solvent wetting composition
07/06/2006US20060147504 Feminine anti-itch cloth
07/06/2006US20060147503 Oil absorbent wipe with high crumpability
07/06/2006US20060147502 Methods for controlling microbial pathogens on currency and mail
07/06/2006US20060147501 Collagen compositions and biomaterials
07/06/2006US20060147498 Composition material for transmucosal delivery
07/06/2006US20060147496 Diagnosis of irritable bowel disorders; fibromyalgia; chronic fatique syndrome; antidepressants; tinnitus; autism; autoimmune disease; Crohn's disease; quantitative analysis of serotonine, bile acid in sample
07/06/2006US20060147493 Packaging and dispensing of rapid dissolve dosage form
07/06/2006US20060147490 New polymers and applications
07/06/2006US20060147488 increasing tear resistance of scar tissue during wound repair by applying to a wound a surgical mesh comprising an anabolic steroid and a corticosteroid disposed in or on a surgical mesh structure
07/06/2006US20060147483 Hydrogel string medical device
07/06/2006US20060147482 Oral liquid pharmaceutical composition of leukotriene antagonists
07/06/2006US20060147481 Ketoprofen powder for oral use
07/06/2006US20060147480 FDA Orange book listed patent for Follitropin alpha/beta a fertility drug; stable formulation, nonprecipitating, includes Pluronic F68 (aka Poloxamer 188), m-cresol as bacteriostat, diluent
07/06/2006US20060147409 Biodegradable hydrogel having a visualization agent that reflects or emits light at a wavelength detectable to a human eye for minimal invasive surgery; crosslinked synthetic polymer having electrophilic functional groups and dilysine, trilysine or tetralysine; dyes provide green color
07/06/2006US20060147390 Cosmetic, dermatological or pharmaceutical preparations of lipid/wax mixtures containing gases
07/06/2006US20060147389 Devices and pharmaceutical compositions for enhancing dosing efficiency
07/06/2006US20060147388 Pharmaceutical compositions for nasal delivery
07/06/2006US20060147387 Process to minimize loss through adhesion to equipment surfaces
07/06/2006US20060147386 System and method for intranasal administration of lorazepam
07/06/2006US20060147383 Sprayable compositions comprising pharmaceutical active agents, volatile silicones and a non-volatile oily phase
07/06/2006US20060146557 Make-up applicator with led light source
07/06/2006US20060145876 Medicine ingestion state management method, medicine and medicine ingestion state management device
07/06/2006US20060145375 Method and apparatus for supercritical fluid assisted particle production
07/06/2006US20060144973 Particle-size reduction apparatus, and use thereof
07/06/2006US20060144535 Surface treatment with texturized microcrystalline cellulose microfibrils for improved paper and paper board
07/06/2006DE202006006162U1 Diabetic socks, to prevent diabetic foot syndrome complications, comprises high silver concentration embedded in knitting, where the moisture is not absorbed by antiabsorbing layer and heat generated is quickly removed by air-opening cord
07/06/2006DE102004061732A1 Controllable several storage cell system for e.g. material delivery, comprises a polymer storage cell, which has a hydrogel structure, a cell carrier, and a media
07/06/2006DE102004035807B4 Device, useful to release/remove substances from inaccessible places, comprises goblet- and circular- shaped part intermediately arranged combined capsule, where one part is continuous magnetic and other is continuous- or soft magnetic
07/06/2006CA2595162A1 Pulmonary surfactant formulations
07/06/2006CA2593862A1 Nanoparticle composition and methods for synthesis thereof
07/06/2006CA2593064A1 Hyaluronic acid linked with a polymer of an alpha hydroxy acid
07/06/2006CA2592437A1 Lyophilization of virosomes
07/06/2006CA2592423A1 Injectable non-aqueous suspension
07/06/2006CA2592323A1 Stabilization of viral compositions
07/06/2006CA2592035A1 Method of treating cancer
07/06/2006CA2591761A1 Stable particulate pharmaceutical composition of solifenacin or salt thereof
07/06/2006CA2591597A1 Novel galenic system for active principle transport, preparation method and use
07/06/2006CA2591056A1 Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it
07/06/2006CA2590239A1 Controlled release compositions
07/06/2006CA2589632A1 Injectable non-aqueous suspension
07/06/2006CA2589515A1 Method for producing sterile suspensions or lyophilisates of poorly soluble basic peptide complexes, pharmaceutical formulations containing the same, and use thereof as medicaments
07/06/2006CA2587388A1 Visco-supplement composition and methods
07/05/2006EP1676912A2 Medical equipment containing a polypeptide having heparanase activity
07/05/2006EP1676895A1 Adhesive patch for external use on skin
07/05/2006EP1676839A2 Novel beta crystalline form of perindopril tert-butylamine salt, its preparation method and pharmaceutical compositions containing same
07/05/2006EP1676602A1 Continuous administration of epitopes derived from protein present in atherosclerotic plaque for the treatment of atherosclerosis
07/05/2006EP1676588A1 Polyarginine-modified liposome capable of transferring into nucleus
07/05/2006EP1676583A2 Therapeutic agent for periodontal disease
07/05/2006EP1676582A1 Anti-coronavirus agent
07/05/2006EP1676581A2 Polymer compositions for use in therapy
07/05/2006EP1676580A1 Glycyrrhizin high-concentration preparation
07/05/2006EP1676579A2 Use of sub-antimicrobial tetracyclines for treating ocular rosacea
07/05/2006EP1676578A1 Method of stabilizing diarylvinylene compound
07/05/2006EP1676569A1 Lyophilization of virosomes
07/05/2006EP1676568A1 Particles comprising phospholipids, process of preparation and use as medicament
07/05/2006EP1676561A2 Compositions containing a biocatalytic polyphasic system and the use thereof
07/05/2006EP1675942A2 Immunogenic composition and method of developing a vaccine based on cyclophilin a binding site
07/05/2006EP1675891A1 Pectin films prepared from gamma irradiated pectin
07/05/2006EP1675869A2 Stabilised compositions
07/05/2006EP1675652A2 Treatment of ocular disease
07/05/2006EP1675635A1 Administration of medicinal dry powders
07/05/2006EP1675619A1 Sustained release l-arginine formulations and methods of manufacture and use
07/05/2006EP1675614A2 Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity
07/05/2006EP1675612A2 Immunogenic composition and method of developing a vaccine based on factor h binding sites
07/05/2006EP1675604A1 Capsulated herbal composition as auxilary medicament against diabetes mellitus type (i) and (ii)
07/05/2006EP1675602A1 Remedy ointment for piles and their manufacturing method
07/05/2006EP1675599A1 Pharmaceutical composition comprising oxoplatin, the salts and derivatives thereof
07/05/2006EP1675596A2 Method
07/05/2006EP1675591A1 Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an acetylcholinesterase inhibitor
07/05/2006EP1675583A1 Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof
07/05/2006EP1675581A1 TREATMENT OF GASTROPARESIS AND NONULCER DYSPEPSIA WITH GABA-b AGONISTS
07/05/2006EP1675580A1 Natural menaquinone 7 compositions
07/05/2006EP1675577A2 Patch
07/05/2006EP1675576A1 A method for preparing modified release pharmaceutical compositions